Oxidized lipids: The two faces of vascular inflammation

被引：43

作者：

Birukov K.G. ^{[1
]}

机构：

[1] Department of Medicine, University of Chicago, Chicago, IL 60637

来源：

Current Atherosclerosis Reports | 2006年 / 8卷 / 3期

关键词：

Arterioscler Thromb Vasc Biol; Endothelial Cell Monolayer; Core Aldehyde; Endothelial Barrier Dysfunction; Cholesteryl Linole;

D O I：

10.1007/s11883-006-0077-x

中图分类号：

学科分类号：

摘要：

Elevated plasma levels of low-density lipoprotein and generation of oxidized low-density lipoprotein have been directly associated with the pathogenesis of atherosclerosis, and lipid oxidation products have been directly linked with induction and propagation of monocytic subendothelial accumulation and other inflammatory reactions associated with chronic vascular inflammation. However, accumulating data suggest that oxidized lipids may also exhibit anti-inflammatory potential and serve as potent inhibitors of nuclear factor-κB-dependent proinflammatory cascade. In addition, we have characterized a group of bioactive components of oxidized phospholipids with barrier-protective effects towards endothelial cells in the models of agonist-induced endothelial permeability and lipopolysaccharide-induced lung dysfunction. This review discusses the role of oxidized lipids in the progression of atherosclerosis as well as the important anti-inflammatory effects of oxidized phospholipids and their potential role in the modulation of vascular barrier integrity. Copyright © 2006 by Current Science Inc.

引用

页码：223 / 231

页数：8

共 50 条

[1]

Watson A.D., Leitinger N., Navab M., Et al., Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte /endothelial interactions and evidence for their presence in vivo, J Biol Chem, 272, pp. 13597-13607, (1997)

[2]

Bochkov V.N., Kadl A., Huber J., Et al., Protective role of phospholipid oxidation products in endotoxin-induced tissue damage, Nature, 419, pp. 77-81, (2002)

[3]

Bochkov V.N., Leitinger N., Anti-inflammatory properties of lipid oxidation products, J Mol Med, 81, pp. 613-626, (2003)

[4]

Stocker R., Keaney Jr. J.F., Role of oxidative modifications in atherosclerosis, Physiol Rev, 84, pp. 1381-1478, (2004)

[5]

Zhang W., Salomon R.G., Oxidized phospholipids, isolevuglandins, and atherosclerosis, Mol Nutr Food Res, 49, pp. 1050-1062, (2005)

[6]

Watson A.D., Subbanagounder G., Welsbie D.S., Et al., Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein, J Biol Chem, 274, pp. 24787-24798, (1999)

[7]

Subbanagounder G., Leitinger N., Schwenke D.C., Et al., Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position, Arterioscler Thromb Vasc Biol, 20, pp. 2248-2254, (2000)

[8]

Navab M., Imes S.S., Hama S.Y., Et al., Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein, J Clin Invest, 88, pp. 2039-2046, (1991)

[9]

Kubes P., Suzuki M., Granger D.N., Nitric oxide: An endogenous modulator of leukocyte adhesion, Proc Natl Acad Sci U S A, 88, pp. 4651-4655, (1991)

[10]

Ehara S., Ueda M., Naruko T., Et al., Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes, Circulation, 103, pp. 1955-1960, (2001)

← 1 2 3 4 5 →